Sangamo’s Research in Alzheimer’s Significantly Reduced Tau Levels in Mice
Acadia Investigates Nuplazid (Pimavanserin) Therapy to Treat Psychosis in Alzheimer’s Patients
June 1, 2017
Seizure-Like Brain Activity May Contribute to Alzheimer’s Development, Study Reports
June 1, 2017
Sangamo’s Research in Alzheimer’s Significantly Reduced Tau Levels in Mice

Promising data from Sangamo Therapeutics‘ research programs, including Alzheimer’s disease, were recently announced.

ReadMore…

Leave a Reply

Your email address will not be published. Required fields are marked *